Perspectives for the future developments of gene therapy for autoimmune and inflammatory therapy

Yuti Chernajovsky, Paul D Robbins

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Important scientific advances in the understanding of the molecular and cellular events that lead to the development of autoimmune inflammatory conditions have identified a number of targets that could be used for the development of therapeutic interventions that exploit gene and cell-mediated delivery.Relevant to these advances are the results of clinical trials using biological agents, genetic and cellular interventions and more recently the discovery of new genetic predisposition genes in multinational genome-wide association studies, epigenetics and its role in disease progression and finally, therapeutic targeting and exploitation of microRNAs. Application of this broad knowledge is being facilitated by the improvement of gene delivery vectors whose characteristics are being constantly improved and transformed to achieve tissue targeting, long-term expression, transcriptional control and low immunogenicity.

Original languageEnglish (US)
Title of host publicationGlutamate-based Therapies for Psychiatric Disorders
EditorsMichael Parnham, Jacques Bruinvels
Pages223-231
Number of pages9
StatePublished - Dec 1 2010
Externally publishedYes

Publication series

NameMilestones in Drug Therapy

Fingerprint Dive into the research topics of 'Perspectives for the future developments of gene therapy for autoimmune and inflammatory therapy'. Together they form a unique fingerprint.

  • Cite this

    Chernajovsky, Y., & Robbins, P. D. (2010). Perspectives for the future developments of gene therapy for autoimmune and inflammatory therapy. In M. Parnham, & J. Bruinvels (Eds.), Glutamate-based Therapies for Psychiatric Disorders (pp. 223-231). (Milestones in Drug Therapy).